Citi Downgrades ResMed (RMD:AU) (RMD) to Neutral

October 31, 2022 3:51 AM EDT
Get Alerts RMD:AU Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 5 | Down: 13 | New: 13
Join SI Premium – FREE

Citi analyst Mathieu Chevrier downgraded ResMed (RMD:AU) (NYSE: RMD) from Buy to Neutral with a price target of AUD37.50 (from AUD38.50).

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades, Intl Ratings